About 2 results
Open links in new tab
  1. SOTYKTU (deucravacitinib) | HCP Page

    SOTYKTU is an efficacious oral treatment that is generally well-tolerated 1–4

  2. Dosing - SOTYKTU

    Dosing oral, once-daily SOTYKTU 6 mg offers patients a once-daily, oral start to advanced therapy 1